Current market catalysts

Nvidia, Oracle, KLA And An Industrial Stock: CNBC’s ‘Final Trades’

CNBC traders picked FTAI Aviation, KLA and Oracle as final trades, while praising NVIDIA’s Hugging Face deal.

Hirain Technologies, Arbe Robotics Say Automotive Group Selects Hirain's Imaging Radar, Powered By Arbe's Radar Chipset, For Level 3 Automated Driving Passenger Vehicle Program In China

Hirain to Begin Series-Production Radar Deliveries in Q4 2027, Ahead of Vehicle Start of ProductionBEIJING and TEL AVIV, Israel, Sept. 8, 2026 /PRNewswire/ -- Hirain Technologies, a provider of world-class electronic

Cantor Fitzgerald Maintains Overweight on Robinhood Markets, Raises Price Target to $150

Cantor Fitzgerald analyst Ramsey El-Assal maintains Robinhood Markets (NASDAQ:HOOD) with a Overweight and raises the price target from $115 to $150.

Bausch Health Announces SILIQ Now Listed Under Alberta's Public Drug Plan For Eligible Moderate To Severe Plaque Psoriasis Patients

Definium Therapeutics Receives FDA Breakthrough Therapy Designation For DT120 ODT; Second Breakthrough Therapy Designation For DT120 Reinforces Its Potential Across MDD And Generalized Anxiety Disorder

The designation was supported by the significant unmet medical need in MDD and results from the Company's Phase 3 Emerge study, in which a single 100 µg dose of DT120 ODT demonstrated a statistically significant

Pulsenmore Announces Completion Of CE Registration Under European MDR For Pulsenmore FC Home Ultrasound System For Follicular, Endometrial Monitoring In IVF And Fertility Preservation

IREN’s 2GW Sweetwater Hub Conditionally Included In Electric Reliability Council Of Texas Batch Zero Process As Base Load

IREN Limited (NASDAQ:IREN) ("IREN") today announced that its 2GW Sweetwater Hub (Sweetwater 1 and Sweetwater 2) has been conditionally included in the Electric Reliability Council of Texas ("ERCOT")

Monte Rosa Therapeutics Announces $50M Milestone Payment From Novartis On First Patient Visit In Phase 2 Study Of MRT-6160 In Sjögren's Disease

DraftKings To Deploy Integrity Compliance 360’s Full Suite Of Integrity And Compliance Technology Across Both Its Sportsbook And Predictions Platform

Integrity Compliance 360, Inc. (IC360), the global technology and advisory leader for integrity and regulatory solutions in sports, sports betting, iGaming, and prediction markets, today announced an agreement with

D-Wave Quantum Announces Definitive Agreement With Commerce Department For Up To $100M In CHIPS Act Funding; Commerce To Receive Minority, Non-Controlling Equity Stake

Lightbridge CEO Says DOE Launch Pad INL Selection Enables Two-Prong Strategy, With SHED Pilot Facility Under DOE Authorization And LEFF Seeking NRC License; Expects Existing Cash Sufficient To Fund SHED

8-K filing — Tonix Pharmaceuticals Holding Corp. (TNXP)

Filed: 2026-09-08 AccNo: 0001493152-26-041689 Size: 250 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

8-K filing — ABM INDUSTRIES INC /DE/ (ABM)

Filed: 2026-09-08 AccNo: 0001193125-26-384364 Size: 786 KB Item 2.02: Results of Operations and Financial Condition Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

8-K filing — KIORA PHARMACEUTICALS INC (KPHMW)

Filed: 2026-09-08 AccNo: 0001372514-26-000079 Size: 257 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Kura Oncology Appoints Jennifer Fulk As CFO, Effective September 8

– Seasoned public company CFO with deep biopharmaceutical finance experience across commercial operations, R&D portfolio management, investor relations, and capital allocation – SAN DIEGO, Sept. 08, 2026 (GLOBE

8-K filing — Kura Oncology, Inc. (KURA)

Filed: 2026-09-08 AccNo: 0001193125-26-384363 Size: 144 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Nkarta Announces Three NKX019 Presentations At ACR Convergence 2026 On November 6-11, Including Two Oral Presentations On Ntrust Phase 1/2 Safety And Idiopathic Inflammatory Myopathy Activity

8-K filing — OneWater Marine Inc. (ONEW)

Filed: 2026-09-08 AccNo: 0001772921-26-000046 Size: 147 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits

Palantir And Nebius Enter Strategic Partnership To Deliver AI-Native Compute Infrastructure And Cloud Platform To Palantir's Commercial Customers

As part of the partnership, Palantir has named Nebius its preferred sovereign AI infrastructure partner and, following the integration period, will bring Nebius compute and inference endpoints inside the Palantir

X4 Pharmaceuticals Says FDA Agreed To Reduce Phase 3 4WARD Chronic Neutropenia Trial Size From 176 To 126 Participants; Expects Enrollment Completion By Year-End 2026, Topline Data In H1 2028

Beamr Imaging Joins VAST Cosmos Community As Technology Partner

Beamr joins the VAST Cosmos Partner Program. First broadcast demonstration at IBC 2026, September 11–14, AmsterdamHerzliya, Israel, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Beamr Imaging Ltd. (NASDAQ:BMR), a leader in video

8-K filing — WILLIS LEASE FINANCE CORP (WLFC)

Filed: 2026-09-08 AccNo: 0001018164-26-000074 Size: 1 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

ZIM Stock Jumps Nearly 7% Premarket: What's Going On?

ZIM shares jumped nearly 6% premarket as Hapag-Lloyd & FIMI revised their $4.2B acquisition bid to address Israeli security concerns.

Palladyne AI And FANUC America Announce Strategic Collaboration Focused On Advancing Next Gen Of Intelligent Robotic Automation

Collaboration to combine FANUC America’s industrial robot portfolio with Palladyne AI’s physical AI software platform to simplify deployment, increase adaptability, and expand automation across manufacturing,

8-K filing — VisionWave Holdings, Inc. (VWAVW)

Filed: 2026-09-08 AccNo: 0001731122-26-001205 Size: 9 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

8-K filing — Monte Rosa Therapeutics, Inc. (GLUE)

Filed: 2026-09-08 AccNo: 0001193125-26-384360 Size: 246 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

8-K filing — UNITED NATURAL FOODS INC (UNFI)

Filed: 2026-09-08 AccNo: 0001020859-26-000022 Size: 570 KB Item 2.02: Results of Operations and Financial Condition Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Bristol Myers Squibb Reports Phase 2 Results From Registrational QUINTESSENTIAL Trial Of Arlocabtagene Autoleucel In Quadruple-Class Exposed RRMM Patients; Trial Met Primary Endpoint Of Overall Response Rate And Key Secondary Endpoint Of Complete Response Rate

Trial met primary endpoint of overall response rate and key secondary endpoint of complete response rate in this heavily pretreated patient population who have been exposed to a prior BCMA-targeted therapyQUINTESSENTIAL

United Natural Foods Sees FY2027 GAAP EPS $1.70-$2.30 vs $2.73 Est

United Natural Foods (NYSE:UNFI) is looking for FY2027 GAAP EPS of $1.70-$2.30 vs $2.73 analyst estimate..

United Natural Foods Sees FY2027 Adj EPS $3.00-$3.50 vs $3.22 Est; Sees Sales $31.200B-$31.800B vs $31.858B Est

United Natural Foods (NYSE:UNFI) is looking for FY2027 Adj EPS of $3.00-$3.50 vs $3.22 analyst estimate. sees sales of $31.200 billion-$31.800 billion vs $31.858 billion analyst estimate.